Trade Summary

2 days ago, Bodenstedt Matthias, serving as Chief Financial Officer at MoonLake Immunotherapeutics (MLTX), sold 17,876 shares at $19.67 per share, for a total transaction value of $351,576.16. Following this transaction, Bodenstedt Matthias now holds 1,154,555 shares of MLTX.

This sale represents a 1.52% decrease in Bodenstedt Matthias's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, June 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 18, 2026 at 6:45 PM ET, 1 day after the trade was made.

MoonLake Immunotherapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.